Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02796430
Other study ID # 15-137
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 10, 2017
Est. completion date July 19, 2019

Study information

Verified date July 2019
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will evaluate the ease of use of the new calorimeter (Q-NRG (COSMED, Italy)) in intensive care unit (ICU) patients compared to currently used calorimeters (i.e. Quark RMR 1.0(COSMED, Italy) or Deltatrac Metabolic Monitor (Datex, Finland)), as well as the stability and the feasibility of the measurements in various clinically relevant situations.

Time needed to prepare and start indirect calorimetry (IC) measurement will be compared as the measure of the ease of use of the calorimeter.


Description:

Background and Aims:

This study aims at evaluating the ease of use of the new calorimeter for the measurement of energy expenditure (EE) in intensive care unit (ICU) patients. EE in ICU patients is highly variable depending on the severity of the disease and treatments. Clinicians need to measure EE by indirect calorimetry (IC) to optimize nutritional support for the better clinical outcome. However, indirect calorimeters available on the market have insufficient accuracy for clinical and research use. Difficulties of handling and interpretation of results often limit IC in ICU patients. An accurate, easy-to-use calorimeter has been developed to meet these needs.

The Study Device:

The new calorimeter (Q-NRG, COSMED) is capable of IC measurements in mechanically ventilated patients without warm-up and limited calibration. The disposable in-line pneumotach flow meter and direct sampling of respiratory gas from the ventilator circuit enables the accurate measurement of oxygen consumption volume (VO2) and CO2 production volume (VCO2) to derive the energy expenditure. The software interface to manage the device and the collected data provides easy-to-use, user-friendly interface. Q-NRG does not bear the European Commission Conformity Mark (CE Mark), but has been approved by the Swiss authority for medical devices (Swissmedic) for use in this study. Q-NRG will be used in the way it is intended to be used as described in the instruction manual.

Currently used indirect calorimeters at each study center will be used as the comparator.


Recruitment information / eligibility

Status Completed
Enrollment 272
Est. completion date July 19, 2019
Est. primary completion date July 19, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Mechanically ventilated adult ICU patients

Exclusion Criteria:

- Fraction of inhaled oxygen (FIO2) > 70%

- Positive end expiratory pressure (PEEP) >10cmH2O

- Peak ventilatory pressure > 30cmH2O

- Presence of air leaks from thoracic drain tube

- Changes in vasoactive agent dose (>20%, <1 hr before and/or during IC)

- Agitation or change in sedative dose (>20%, <1 hr before and/or during IC)

- Change in body temperature (>0.5°C, <1 hr before and/or during IC)

- Expected duration of ICU stay < 24 hours

- Expected survival of the patient < 24 hours

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Time needed to start indirect calorimetry measurement
Comparison of the time needed to start EE measurements by the new calorimeter and the currently used calorimeter, including the time needed for calibration, patient data input, connection to the ventilator circuit.
Indirect calorimetry measurement
Comparison of EE measurements by the new calorimeter and the currently used calorimeter when using different mechanical ventilators, different ventilation modes, different patient conditions and severity

Locations

Country Name City State
Austria Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine Vienna
Belgium Department of Intensive Care, Vrije Universiteit Brussel Brussels
Israel Critical Care Medicine, Institute for Nutrition Research, Rabin Medical Center, Beilison Hospital Petah Tikva
Japan Chiba University Hospital Chiba
Sweden Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital Huddinge
Switzerland Service of Intensive Care, Geneva University Hospital Geneva
Switzerland Adult Intensive care, Lausanne University Hospital Lausanne

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Geneva European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Intensive Care Medicine

Countries where clinical trial is conducted

Austria,  Belgium,  Israel,  Japan,  Sweden,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time needed to start indirect calorimetry (IC) measurement in Q-NRG compared to currently used calorimeters Time from the start-up of the devices until the 1st recorded measurement will be measured and compared between Q-NRG and the currently used indirect calorimeters, including time needed for patient information input, warm-up and calibrations according to the instructions for the devices, and installation of the device components needed for the measurements on patients. immediately after the measurement
Secondary Comparison of energy expenditure(EE) from Q-NRG and currently used calorimeters EE measured by Q-NRG and currently used calorimeters will be compared to identify the differences of the characteristics of the measurements according to the different types of calorimeters. immediately after the measurement
Secondary Coefficient of variation (CV) of EE for different mechanical ventilators CV of EE measured by Q-NRG when using different mechanical ventilators will be analyzed to evaluate the effects of the mechanical ventilators used during the indirect calorimetry measurement. immediately after the measurement
Secondary CV of EE when using different ventilation modes CV of EE measured by Q-NRG when using different mechanical ventilation modes will be analyzed to evaluate the effect of different mechanical ventilation modes used during the indirect calorimetry measurement. immediately after the measurement
Secondary CV of EE in various ranges of oxygen and airway pressure support CV of EE measured by the Q-NRG in different ranges of FiO2 will be analyzed to evaluate the difference in the stability of the measurements according to various FiO2 ranges. immediately after the measurement
Secondary CV of EE when measured in different sedation/consciousness levels CV of EE measured by the Q-NRG in different levels of sedation/consciouness will be analyzed to evaluate the difference in the stability of the measurements according to various sedation/consciousness levels. immediately after the measurement
Secondary CV of EE when measured in different levels of patient severity CV of EE measured by the Q-NRG in different levels of patient severity will be analyzed to evaluate the difference in the stability of the measurement according to various levels of severity. immediately after the measurement
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness